<DOC>
	<DOCNO>NCT02024412</DOCNO>
	<brief_summary>The morbidity colorectal cancer ( CRC ) 10 % ～15 % China.mFolfox6 become one standard regimes metastatic colorectal cancer ( mCRC ) . Neutropenia oxaliplatin-induced neurotoxicity common adverse effect even result discontinue chemotherapy , especially patient suffer heavily acute neurotoxicity . Monosialotetrahexosylganglioside component membrane nerve cell . Previous phase II clinical trial show , reduce oxaliplatin-induced neurotoxicity ( OIN ) . But certificate phase III trial . Investigators design phase III trial investigate effect safety monosialotetrahexosylganglioside Sodium Injection prevention OIN colorectal cancer .</brief_summary>
	<brief_title>Monosialotetrahexosylganglioside Sodium Injection Prevention Neurotoxicity mFOLFOX 6 mCRC</brief_title>
	<detailed_description>placebo control phase III trial . investigator plan enroll 240 patient 1:1 A arm B arm</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neurotoxicity Syndromes</mesh_term>
	<criteria>1 . Patients shall normal organic function liver function , Cardiac function renal function ; 2. age &gt; 18 year old ; 3. diagnosis mCRC histology ; 4 . Did receive firstline chemotherapy 5 . Karnofsky Performance score &gt; 70 score 6. target lesion nontarget lesion 7 . For patient receive oxaliplatin , residual neurotoxicity less grade 2 8 . For diabetes without neuropathy , blood glucose meal le 8mmol/L HBA1C &lt; 7.0 % 9 . Patients expect live short 3 month 1. patient receive chemotherapy ; 2 . WBC＜4.0×109/L，ANC＜1.5×109/L , PLT＜100×109/L，Hb＜90g/L , TBIL＞1.5Limitation ; BUN）＞1.5Limitation；Cr）＞1.5Limitation；ALT AST＞2.5Limitation（without liver metastasis）；ALT AST）＞5Limitation（with liver metastasis） ; 3. heart dysfunction ; 4. brain metastasis ; 5. peripheral nervous system central nervous system abnormal include diabetes mellitus patient neuropathy ; 6. patient receive Glutathione , acetylcysteine , calcium / magnesium , amifostine , carbamazepine , B vitamins , vitamin E within 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>metastatic colorectal cancer</keyword>
	<keyword>neurotoxicity</keyword>
	<keyword>mFOLFOX6</keyword>
	<keyword>monosialotetrahexosylganglioside Sodium Injection</keyword>
</DOC>